Publicaciones

Early Retention in Care Neither Mediates Nor Modifies the Effect of Sex and Sexual Mode of HIVAcquisition on HIV Survival in the Americas. Coelho L, Rebeiro PF, Castilho JL, Caro-Veja Y, Mejia FA, Cesar C, Cortes CP, Padgett D, McGowan CC, Veloso VG, Sterling TR, Grinsztejn B, Shepherd BE, Luz PM.AIDS Patient Care STDS. 2018 Aug;32(8):306-313

Las personas que viven con VIH / SIDA: diferencias étnicas y socioculturales en Chile. Alarcón AM, Chahin C, Muñoz S, Wolff M , Northland R. Rev Chilena Infectol . 2018; 35 (3): 276-282

Evolution of mortality, retention and loss to follow up of HIV infected subjects followed in a special clinic. Cortés CP, Lizana D, Northland R, Wolff R M. Rev Med Chil. 2018 Mar;146(3):290-299.

Survival after cancer diagnosis in a cohort of HIV-positive individuals in Latin America.
Fink VI, Jenkins CA, Castilho JL, Person AK, Shepherd BE, Grinsztejn B, Netto J, Crabtree-Ramirez B, Cortés CP, Padgett D, Jayathilake K, McGowan C, Cahn P; CCASAnet.
Infect Agent Cancer. 2018 May 8;13:16.

Virologic failure and mortality in older ART initiators in a multisite Latin American and Caribbean Cohort.
Carriquiry G, Giganti MJ, Castilho JL, Jayathilake K, Cahn P, Grinsztejn B, Cortes C, Pape JW, Padgett D, Sierra-Madero J, McGowan CC, Shepherd BE, Gotuzzo E. J Int AIDS Soc. 2018 Mar;21(3):e25088.

Is substance use associated with HIV cascade outcomes in Latin America?
De Boni RB, Peratikos MB, Shepherd BE, Grinsztejn B, Cortés C, Padgett D, Gotuzzo E, Belaunzarán-Zamudio PF, Rebeiro PF, Duda SN, McGowan CC; for CCASAnet.
PLoS One. 2018 Mar 15;13(3):e0194228.

Trends in proportion of older HIV-infected people in care in Latin America and the Caribbean: a growing challenge.
Caro-Vega Y, Belaunzarán-Zamudio PF, Crabtree-Ramírez B, Shepherd BE, Mejia F, Giganti MJ, Patterson P, Grinsztejn B, Wolff M, Pape JW, Padgett D, Castilho JL, McGowan C, Sierra-Madero JG.
Epidemiol Infect. 2018 Jul;146(10):1308-1311.

Durability of Efavirenz Compared With Boosted Protease Inhibitor-Based Regimens in Antiretroviral-Naïve Patients in the Caribbean and Central and South America.
Caro-Vega Y, Belaunzarán-Zamudio PF, Crabtree-Ramírez BE, Shepherd BE, Grinsztejn B, Wolff M, Pape JW, Padgett D, Gotuzzo E, McGowan CC, Sierra-Madero JG.
Open Forum Infect Dis. 2018 Mar 2;5(3):ofy004.

Crabtree Ramírez B, Caro Vega Y, Shepherd BE, Le C, Turner M, Frola C, Grinsztejn B, Cortes C, Padgett D, Sterling TR, et al.Int J Infect Dis. Outcomes of HIV-positive patients with cryptococcal meningitis in the Americas. 2017 Oct;63:57-63.

Week 96 results of the randomized, multicentre Maraviroc Switch (MARCH) study.
Pett SL, Amin J, Horban A, Andrade-Villanueva J, Losso M, Porteiro N, Madero JS, Belloso W, Tu E, Silk D, Kelleher A, Harrigan R, Clark A, Sugiura W, Wolff M, Gill J, Gatell J, Clarke A, Ruxrungtham K, Prazuck T, Kaiser R, Woolley I, Alberto Arnaiz J, Cooper D, Rockstroh JK, Mallon P, Emery S; MARCH study group.
HIV Med. 2018 Jan;19(1):65-71.

Jiamsakul A, Kariminia A, Althoff KN, Cesar C, Cortes CP, Davies MA, Do VC, Eley B, Gill J, Kumarasamy N, et al.  J Acquir Immune Defic Syndr. HIV Viral Load Suppression in Adults and Children Receiving Antiretroviral Therapy-Results From the IeDEA Collaboration. 2017 Nov 1;76(3):319-329.

De Boni RB, Shepherd BE, Grinsztejn B, Cesar C, Cortés C, Padgett D, Gotuzzo E, Belaunzarán-Zamudio PF, Rebeiro PF, Duda SN, McGowan CC. Substance Use and Adherence Among People Living with HIV/AIDS Receiving cART in Latin America.AIDS Behav. 2016 Nov;20(11):2692-2699. PubMed PMID: 27091028; PubMed Central PMCID: PMC5069110.

Crabtree-Ramírez B, Caro-Vega Y, Shepherd BE, Grinsztejn B, Wolff M, Cortes CP, Padgett D, Carriquiry G, Fink V, Jayathilake K, Person AK, McGowan C, Sierra-Madero J; Caribbean, Central and South America Network for HIV Epidemiology (CCASAnet), of the International Epidemiologic Databases to Evaluate AIDS (IeDEA) Program.. Time to HAART Initiation after Diagnosis and Treatment of Opportunistic Infections in Patients with AIDS in Latin America.PLoS One. 2016 Jun 7;11(6):e0153921. doi: 10.1371/journal.pone.0153921. PubMed PMID: 27271083; PubMed Central PMCID: PMC4896474.

Lazcano C, Millacura JC, Saavedra F, Cortés CP. [Evaluation of cardiovascular risk in HIV positive patients in a specialized center at Santiago, Chile].Rev Chilena Infectol. 2016 Jun;33(3):352-4. doi: 10.4067/S0716-10182016000300018. Spanish. PubMed PMID: 27598289.

Charles MK, Lindegren ML, Wester CW, Blevins M, Sterling TR, Dung NT, Dusingize JC, Avit-Edi D, Durier N, Castelnuovo B, Nakigozi G, Cortes CP, Ballif M, Fenner L; International epidemiology Databases to Evaluate AIDS (IeDEA) Collaboration.. Implementation of Tuberculosis Intensive Case Finding, Isoniazid Preventive Therapy, and Infection Control («Three I’s») and HIV-Tuberculosis Service Integration in Lower Income Countries.PLoS One. 2016 Apr 13;11(4):e0153243. doi: 10.1371/journal.pone.0153243. PubMed PMID: 27073928; PubMed Central PMCID: PMC4830552.

Althoff KN, Rebeiro PF, Hanna DB, Padgett D, Horberg MA, Grinsztejn B, Abraham AG, Hogg R, Gill MJ, Wolff MJ, Mayor A, Rachlis A, Williams C, Sterling TR, Kitahata MM, Buchacz K, Thorne JE, Cesar C, Cordero FM, Rourke SB, Sierra-Madero J, Pape JW, Cahn P, McGowan C; North American Aids Cohort Collaboration on Research and Design (NA-ACCORD) and Caribbean, Central and South America Network forHiv Epidemiology (CCASAnet). A picture is worth a thousand words: maps of HIV indicators to inform research, programs, and policy from NA-ACCORD and CCASAnet clinical cohorts. J Int AIDS Soc. 2016 Apr 4;19(1):20707. doi: 10.7448/IAS.19.1.20707

Pett SL, Amin J, Horban A, Andrade-Villanueva J, Losso M, Porteiro N, Sierra Madero J, Belloso W, Tu E, Silk D, Kelleher A, Harrigan R, Clark A, Sugiura W, Wolff M, Gill J, Gatell J, Fisher M, Clarke A, Ruxrungtham K, Prazuck T, Kaiser R, Woolley I, Arnaiz JA, Cooper D, Rockstroh JK, Mallon P, Emery S; Maraviroc Switch (MARCH) Study Group. Maraviroc, as a Switch Option, in HIV-1-infected Individuals With Stable, Well-controlled HIVReplication and R5-tropic Virus on Their First Nucleoside/Nucleotide Reverse Transcriptase Inhibitor Plus Ritonavir-boosted Protease Inhibitor Regimen: Week 48 Results of the Randomized, Multicenter MARCH Study. Clin Infect Dis. 2016 Jul 1;63(1):122-32. doi: 10.1093/cid/ciw207.

Rebeiro PF, Cesar C, Shepherd BE, De Boni RB, Cortés CP, Rodriguez F, Belaunzarán-Zamudio P, Pape JW, Padgett D, Hoces D, McGowan CC, Cahn P. Assessing the HIV Care Continuum in Latin America: progress in clinical retention, cART use and viral suppression.J Int AIDS Soc. 2016 Apr 8;19(1):20636. doi: 10.7448/IAS.19.1.20636. PubMed PMID: 27065108; PubMed Central PMCID: PMC4827101.

Cesar C, Koethe JR, Giganti MJ, Rebeiro P, Althoff KN, Napravnik S, Mayor A, Grinsztejn B, Wolff M, Padgett D, Sierra-Madero J, Gotuzzo E, Sterling TR, Willig J, Levison J, Kitahata M, Rodriguez-Barradas MC, Moore RD, McGowan C, Shepherd BE, Cahn P; Caribbean, Central and South America Network for HIVepidemiology (CCASAnet) and North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). Health outcomes among HIV-positive Latinos initiating antiretroviral therapy in North America versus Central and South America. J Int AIDS Soc. 2016 Mar 18;19(1):20684. doi: 10.7448/IAS.19.1.20684. PMID:26996992

Wolff M, Shepherd BE, Cortés C, Rebeiro P, Cesar C, Wagner Cardoso S, Pape JW, Padgett D, Sierra-Madero J, Echevarria J, McGowan CC; Caribbean, Central and South America Network for HIV Epidemiology.. Clinical and Virologic Outcomes After Changes in First Antiretroviral Regimen at 7 Sites in the Caribbean, Central and South America Network.J Acquir Immune Defic Syndr. 2016 Jan 1;71(1):102-10. doi: 10.1097/QAI.0000000000000817. PubMed PMID: 26761273; PubMed Central PMCID: PMC4712722.

Cesar C, Jenkins CA, Shepherd BE, Padgett D, Mejía F, Ribeiro SR, Cortes CP, Pape JW, Madero JS, Fink V, Sued O, McGowan C, Cahn P; Caribbean, Central and South America Network for HIV Epidemiology (CCASAnet) of the International Epidemiologic Databases to Evaluate AIDS (IeDEA) Program.. Incidence of virological failure and major regimen change of initial combination antiretroviral therapy in the Latin America and the Caribbean: an observational cohort study.Lancet HIV. 2015 Nov;2(11):e492-500. doi: 10.1016/S2352-3018(15)00183-6. PubMed PMID: 26520929; PubMed Central PMCID: PMC4651009.

Crabtree-Ramírez B, Vega YN, Shepherd BE, Turner M, Carriquiry G, Fink V, Luz PM, Cortes CP, Rouzier V, Padgett D, Jayathilake K, McGowan CC, Person AK. Temporal Trends in Age at HIV Diagnosis in Cohorts in the United States, the Caribbean, and Central and South America.AIDS Behav. 2015 Sep;19(9):1599-608. doi: 10.1007/s10461-014-0974-x. PubMed PMID: 25613592; PubMed Central PMCID: PMC4512939.

Belaunzarán-Zamudio PF, Caro-Vega YN, Shepherd BE, Crabtree-Ramírez BE, Luz PM, Grinsztejn B, Cesar C, Cahn P, Cortés C, Wolff M, Pape JW, Padgett D, Gotuzzo E, McGowan C, Sierra-Madero JG; CCASAnet.. Monitoring of HIV treatment in seven countries in the WHO Region of the Americas.Bull World Health Organ. 2015 Aug 1;93(8):529-39. doi: 10.2471/BLT.14.147447. PubMed PMID: 26478610; PubMed Central PMCID: PMC4581655.

Carriquiry G, Fink V, Koethe JR, Giganti MJ, Jayathilake K, Blevins M, Cahn P, Grinsztejn B, Wolff M, Pape JW, Padgett D, Madero JS, Gotuzzo E, McGowan CC, Shepherd BE. Mortality and loss to follow-up among HIV-infected persons on long-term antiretroviral therapy in Latin America and the Caribbean.J Int AIDS Soc. 2015 Jul 10;18:20016. doi: 10.7448/IAS.18.1.20016. PubMed PMID: 26165322; PubMed Central PMCID: PMC4499577.

Luz PM, Belaunzarán-Zamudio PF, Crabtree-Ramírez B, Caro-Vega Y, Hoces D, Rebeiro PF, Blevins M, Pape JW, Cortes CP, Padgett D, Cahn P, Veloso VG, McGowan CC, Grinsztejn B, Shepherd BE. CD4 Response Up to 5 Years After Combination Antiretroviral Therapy in Human Immunodeficiency Virus-Infected Patients in Latin America and the Caribbean.Open Forum Infect Dis. 2015 Jun 5;2(2):ofv079. doi: 10.1093/ofid/ofv079. PubMed PMID: 26180829; PubMed Central PMCID: PMC4498272.

Ballif M, Renner L, Claude Dusingize J, Leroy V, Ayaya S, Wools-Kaloustian K, Cortes CP, McGowan CC, Graber C, Mandalakas AM, Mofenson LM, Egger M, Kumara Wati KD, Nallusamy R, Reubenson G, Davies MA, Fenner L; International Epidemiologic Databases to Evaluate AIDS (IeDEA).; International Epidemiologic Databases to Evaluate AIDS IeDEA.. Tuberculosis in Pediatric Antiretroviral Therapy Programs in Low- and Middle-Income Countries: Diagnosis and Screening Practices.J Pediatric Infect Dis Soc. 2015 Mar;4(1):30-8. doi: 10.1093/jpids/piu020. PubMed PMID: 26407355.

Boyd MA, Moore CL, Molina JM, Wood R, Madero JS, Wolff M, Ruxrungtham K, Losso M, Renjifo B, Teppler H, Kelleher AD, Amin J, Emery S, Cooper DA; SECOND-LINE study group.Baseline HIV-1 resistance, virological outcomes, and emergent resistance in the SECOND-LINE trial: an exploratory analysis. Lancet HIV. 2015 Feb;2(2):e42-51. doi: 10.1016/S2352-3018(14)00061-7. PMID:26424460.

Valdebenito C, Bonacic M, Matamala J, Wolff M.[Extrapulmonary pneumocystosis: a case report]. Rev Chilena Infectol. 2015 Jun;32(3):344-9. doi: 10.4067/S0716-10182015000400015. PMID: 26230444

MF, Wolff M, Cortés C. [Clinical and epidemiological characteristics of HIV infection in Latin-American immigrants: comparative analysis from clinical records in a clinical care centre in Santiago in the last decade]. Rev Chilena Infectol. 2015 Feb;32 Suppl 1:S72-80. doi: 10.4067/S0716-10182015000100006. Spanish. PubMed PMID: 25860155.

Duda SN, Farr AM, Lindegren ML, Blevins M, Wester CW, Wools-Kaloustian K, Ekouevi DK, Egger M, Hemingway-Foday J, Cooper DA, Moore RD, McGowan CC, Nash D; International Epidemiologic Databases to Evaluate AIDS (IeDEA) Collaboration.. Characteristics and comprehensiveness of adult HIV care and treatment programmes in Asia-Pacific, sub-Saharan Africa and the Americas: results of a site assessment conducted by the International epidemiologic Databases to Evaluate AIDS (IeDEA) Collaboration.J Int AIDS Soc. 2014 Dec 15;17:19045. doi: 10.7448/IAS.17.1.19045. PubMed PMID: 25516092; PubMed Central PMCID: PMC4268491.

ENCORE1 Study Group., Puls R, Amin J, Losso M, Phanuphak P, Nwizu C, Orrell C, Young B, Shahar E, Wolff M, Gazzard B, Read T, Hill A, Cooper DA, Emery S. Efficacy of 400 mg efavirenz versus standard 600 mg dose in HIV-infected, antiretroviral-naive adults (ENCORE1): a randomised, double-blind, placebo-controlled, non-inferiority trial. Lancet. 2014 Apr 26;383(9927):1474-82. doi: 10.1016/S0140-6736(13)62187-X. Erratum in: Lancet. 2014 Apr 26;383(9927):1464.PMID:24522178

IeDEA and ART Cohort Collaborations., Avila D, Althoff KN, Mugglin C, Wools-Kaloustian K, Koller M, Dabis F, Nash D, Gsponer T, Sungkanuparph S, McGowan C, May M, Cooper D, Chimbetete C, Wolff M, Collier A, McManus H, Davies MA, Costagliola D, Crabtree-Ramirez B, Chaiwarith R, Cescon A, Cornell M, Diero L, Phanuphak P, Sawadogo A, Ehmer J, Eholie SP, Li PC, Fox MP, Gandhi NR, González E, Lee CK, Hoffmann CJ, Kambugu A, Keiser O, Ditangco R, Prozesky H, Lampe F, Kumarasamy N, Kitahata M, Lugina E, Lyamuya R, Vonthanak S, Fink V, d’Arminio Monforte A, Luz PM, Chen YM, Minga A, Casabona J, Mwango A, Choi JY, Newell ML, Bukusi EA, Ngonyani K, Merati TP, Otieno J, Bosco MB, Phiri S, Ng OT, Anastos K, Rockstroh J, Santos I, Oka S, Somi G, Stephan C, Teira R, Wabwire D, Wandeler G, Boulle A, Reiss P, Wood R, Chi BH, Williams C, Sterne JA, Egger M. Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries. J Acquir Immune Defic Syndr. 2014 Jan 1;65(1):e8-16. doi: 10.1097/QAI.0b013e3182a39979. PMID:24419071

Ballif M, Nhandu V, Wood R, Dusingize JC, Carter EJ, Cortes CP, McGowan CC, Diero L, Graber C, Renner L, Hawerlander D, Kiertiburanakul S, Du QT, Sterling TR, Egger M, Fenner L; International epidemiological Databases to Evaluate AIDS (IeDEA).. Detection and management of drug-resistant tuberculosis in HIV-infected patients in lower-income countries.Int J Tuberc Lung Dis. 2014 Nov;18(11):1327-36. doi: 10.5588/ijtld.14.0106. PubMed PMID: 25299866; PubMed Central PMCID: PMC4323497.

Cesar C, Shepherd BE, Jenkins CA, Ghidinelli M, Castro JL, Veloso VG, Cortes CP, Padgett D, Crabtree-Ramirez B, Gotuzzo E, Fink V, Duran A, Sued O, McGowan CC, Cahn P; Caribbean, Central and South America Network for HIV Epidemiology (CCASAnet).. Use of third line antiretroviral therapy in Latin America.PLoS One. 2014 Sep 15;9(9):e106887. doi: 10.1371/journal.pone.0106887. PubMed PMID: 25221931; PubMed Central PMCID: PMC4164470.

Fenner L, Ballif M, Graber C, Nhandu V, Dusingize JC, Cortes CP, Carriquiry G, Anastos K, Garone D, Jong E, Gnokoro JC, Sued O, Ajayi S, Diero L, Wools-Kaloustian K, Kiertiburanakul S, Castelnuovo B, Lewden C, Durier N, Sterling TR, Egger M; International epidemiological Databases to Evaluate AIDS (IeDEA).. Tuberculosis in antiretroviral treatment programs in lower income countries: availability and use of diagnostics and screening.PLoS One. 2013 Oct 17;8(10):e77697. doi: 10.1371/journal.pone.0077697. PubMed PMID: 24147059; PubMed Central PMCID: PMC3798412.

Otto-Knapp R, Cortes CP, Saavedra F, Wolff M, Weitzel T. Hepatitis B prevalence and influence on HIV treatment outcome and mortality in the Chilean AIDS Cohort.Int J Infect Dis. 2013 Oct;17(10):e919-24. doi: 10.1016/j.ijid.2013.05.009. PubMed PMID: 23849398.

Cortes CP, Wehbe FH, McGowan CC, Shepherd BE, Duda SN, Jenkins CA, Gonzalez E, Carriquiry G, Schechter M, Padgett D, Cesar C, Madero JS, Pape JW, Masys DR, Sterling TR; Caribbean, Central American, South American Network for HIV Research of the International Epidemiologic Databases to Evaluate AIDS.. Duration of anti-tuberculosis therapy and timing of antiretroviral therapy initiation: association with mortality in HIV-related tuberculosis.PLoS One. 2013 Sep 16;8(9):e74057. doi: 10.1371/journal.pone.0074057. PubMed PMID: 24066096; PubMed Central PMCID: PMC3774609.

Pizarro A, García H, Riquelme A, Carmona J, Cortés C. [Lymphomas associated with HIV infection in patients at the Hospital San Borja Arriarán /Fundación Arriarán 2001-2008, Santiago, Chile].Rev Chilena Infectol. 2013 Feb;30(1):23-30. doi: 10.4067/S0716-10182013000100004. Spanish. PubMed PMID: 23450406.

Cortes CP, Siccardi M, Chaikan A, Owen A, Zhang G, la Porte CJ. Correlates of efavirenz exposure in Chilean patients affected with human immunodeficiency virus reveals a novel association with a polymorphism in the constitutive androstane receptor.Ther Drug Monit. 2013 Feb;35(1):78-83. doi: 10.1097/FTD.0b013e318274197e. PubMed PMID: 23172109.

Wilson G, Wolff M. [A decade of antiretroviral therapy: a profile of patients with 10 years of highly effective triple therapy]. Rev Chilena Infectol. 2012 Jun;29(3):337-43. doi: 10.4067/S0716-10182012000300015. PMID:23096476

Fink VI, Shepherd BE, Cesar C, Krolewiecki A, Wehbe F, Cortés CP, Crabtree-Ramírez B, Padgett D, Shafaee M, Schechter M, Gotuzzo E, Bacon M, McGowan C, Cahn P, Masys D; Caribbean Central South America Network for HIV Research Collaboration of the International Epidemiologic Databases to Evaluate AIDS Program.. Cancer in HIV-infected persons from the Caribbean, Central and South America.J Acquir Immune Defic Syndr. 2011 Apr 15;56(5):467-73. doi: 10.1097/QAI.0b013e31820bb1c3. PubMed PMID: 21239992; PubMed Central PMCID: PMC3293455.

Crabtree-Ramírez B, Caro-Vega Y, Shepherd BE, Wehbe F, Cesar C, Cortés C, Padgett D, Koenig S, Gotuzzo E, Cahn P, McGowan C, Masys D, Sierra-Madero J; CCASAnet Team.. Cross-sectional analysis of late HAART initiation in Latin America and the Caribbean: late testers and late presenters.PLoS One. 2011;6(5):e20272. doi: 10.1371/journal.pone.0020272. PubMed PMID: 21637802; PubMed Central PMCID: PMC3102699.

Wolff MJ, Cortés CP, Shepherd BE, Beltrán CJ; Chilean AIDS Cohort Study Group.. Long-term outcomes of a national expanded access program to antiretroviral therapy: the Chilean AIDS cohort.J Acquir Immune Defic Syndr. 2010 Nov;55(3):368-74. doi: 10.1097/QAI.0b013e3181eb4fb9. PubMed PMID: 20683194.

Carr DF, la Porte CJ, Pirmohamed M, Owen A, Cortes CP. Haplotype structure of CYP2B6 and association with plasma efavirenz concentrations in a Chilean HIV cohort.J Antimicrob Chemother. 2010 Sep;65(9):1889-93. doi: 10.1093/jac/dkq260. PubMed PMID: 20639527; PubMed Central PMCID: PMC2920179.

Cesar C, Shepherd BE, Krolewiecki AJ, Fink VI, Schechter M, Tuboi SH, Wolff M, Pape JW, Leger P, Padgett D, Madero JS, Gotuzzo E, Sued O, McGowan CC, Masys DR, Cahn PE; Caribbean, Central and South America Network for HIV Research (CCASAnet) Collaboration of the International Epidemiologic Databases to Evaluate AIDS (IeDEA) Program. Rates and reasons for early change of first HAART in HIV-1-infected patients in 7 sites throughout the Caribbean and Latin America.PLoS One. 2010 Jun 1;5(6):e10490. doi: 10.1371/journal.pone.0010490. PubMed PMID: 20531956; PubMed Central PMCID: PMC2879360.

Masys DR, Fang F, Ye I, Fink VI, Gotuzzo E, et al. Preliminary findings on cancer incidence in HIV-infected persons from six countries in Central and South America and the Caribbean. Infectious Agents and Cancer. 2009 January; 4(S2).

Tuboi SH, Schechter M, McGowan CC, Cesar C, Krolewiecki A, Cahn P, Wolff M, Pape JW, Padgett D, Madero JS, Gotuzzo E, Masys DR, Shepherd BE Mortality during the first year of potent antiretroviral therapy in HIV-1-infected patients in 7 sites throughout Latin America and the Caribbean. J Acquir Immune Defic Syndr. 2009 Aug 15;51(5):615-23. doi: 10.1097/QAI.0b013e3181a44f0a. PMID:19430306

McGowan CC, Cahn P, Gotuzzo E, Padgett D, Pape JW, Wolff M, Schechter M, Masys DR.Cohort Profile: Caribbean, Central and South America Network for HIV research (CCASAnet) collaboration within the International Epidemiologic Databases to Evaluate AIDS (IeDEA) programme. Int J Epidemiol. 2007 Oct;36(5):969-76. Review.PMID:17846055

Cortés C, Beltrán C, Muñoz R, Daube E, Wolff M; Grupo SIDA Chile.. [Impact of baseline CD4 count, immune recovery and viral suppression at 7 year of first highly active antiretroviral therapy on survival, AIDS defining events and immune recovery reactions].Rev Med Chil. 2008 Dec;136(12):1503-10. doi: /S0034-98872008001200001. Spanish. PubMed PMID: 19350166.

Wolff MJ, Beltrán CJ, Vásquez P, Ayala MX, Valenzuela M, Berríos G, Arredondo A. The Chilean AIDS cohort: a model for evaluating the impact of an expanded access program to antiretroviral therapy in a middle-income country–organization and preliminary results. J Acquir Immune Defic Syndr. 2005 Dec 15;40(5):551-7. PMID:16284531